Cryoport expands into biostorage with Cryogene acquisition

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Yozayo)
(Image: Getty/Yozayo)

Related tags: Cryoport, Logistics, cell and gene therapy, CAR-T

Cryoport acquires Cryogene to gain access to the latter company’s 21,000-square-foot biostorage facility in Houston.

The cold chain logistics firm for the life sciences industry has been looking to add storage services to its offering, Mark Sawicki, Cryoport’s CCO told us ​recently.

The acquisition is structured as an asset purchase and, as stated, it is expected to be immediately accretive to Cryoport's earnings.

The US facility provides storage of biological specimens, materials and samples for clients such as Merck, MD Anderson, Houston Methodist Hospital, Texas Children's Hospital, Mesoblast, Bellicum and Baylor University.

The storage service for biological commodities covers a full range of temperatures, from cryogenic to controlled room temperature, and includes sample inventorying, data sample discrepancy resolution and accessioning samples into its validated data inventory software.

The deal comes after Cryoport expanded the number of its clients recently, including adding Celularity ​to its clients roster.

During the previous year, the company established multiple collaborations ​and boosted its revenue ​by becoming the exclusive distributor of Novartis’ Kymriah​ ​(tisagenlecleucel) and Kite’s Yescarta (axicabtagene ciloleucel), the two approved chimeric antigen receptor (CAR)-T therapies.

Related news

Show more

Related products

show more

Infographic - road map to commercialization

Infographic - road map to commercialization

MilliporeSigma - Gene Therapy | 19-Oct-2020 | Infographic

With the current increase in development and investment, gene therapy companies will increasingly be looking to streamline the manufacture and commercialization...

Process Development for Viral Vector Manufacturing

Process Development for Viral Vector Manufacturing

MilliporeSigma - Gene Therapy | 15-Oct-2020 | Infographic

Process development is a crucial step in viral vector manufacturing and a successful CDMO partnership can help navigate the challenges associated with...

Related suppliers

Follow us

Products

View more

Webinars